These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8813541)
1. Dopamine autoreceptor reserve in vitro: possible role of dopamine D3 receptors. Aretha CW; Galloway MP Eur J Pharmacol; 1996 Jun; 305(1-3):119-22. PubMed ID: 8813541 [TBL] [Abstract][Full Text] [Related]
2. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181 [TBL] [Abstract][Full Text] [Related]
4. Local injection of alkylating and nonalkylating dopamine receptor antagonists into rat basal forebrain: autoradiographic assessment of D2-like and D3 sites. Yeghiayan SK; Gongwer MA; Baldessarini RJ; Kula NS; Zong R; Neumeyer JL Brain Res; 1998 May; 792(2):324-6. PubMed ID: 9593972 [TBL] [Abstract][Full Text] [Related]
5. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis. Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS Eur J Pharmacol; 1996 Jul; 308(3):261-9. PubMed ID: 8858296 [TBL] [Abstract][Full Text] [Related]
6. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study). Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421 [TBL] [Abstract][Full Text] [Related]
7. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452 [TBL] [Abstract][Full Text] [Related]
8. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine. Baker LE; Svensson KA; Garner KJ; Goodwin AK Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258 [TBL] [Abstract][Full Text] [Related]
9. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain. Booth RG; Baldessarini RJ; Marsh E; Owens CE Brain Res; 1994 Oct; 662(1-2):283-8. PubMed ID: 7859086 [TBL] [Abstract][Full Text] [Related]
10. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane. Wallace DR; Booze RM J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063 [TBL] [Abstract][Full Text] [Related]
11. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements. Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292 [TBL] [Abstract][Full Text] [Related]
17. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors. Rogóz Z; Skuza G Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330 [TBL] [Abstract][Full Text] [Related]
18. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Svensson K; Carlsson A; Huff RM; Kling-Petersen T; Waters N Eur J Pharmacol; 1994 Oct; 263(3):235-43. PubMed ID: 7843260 [TBL] [Abstract][Full Text] [Related]
20. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Caine SB; Geyer MA; Swerdlow NR Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]